Collegium Pharmaceutical, Inc. (COLL)

23.52 -0.18 (-0.76%) USD  |  NASDAQ  |  Sep 04, 16:00
23.52 0.00 (0.00%) After-Hours: 20:00
More

Collegium Pharmaceutical Cash and Short Term Investments (Annual) : 406.53M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for COLL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2013. Start Trial.
Date Value
December 31, 2025 406.53M
December 31, 2024 187.76M
December 31, 2023 310.55M
December 31, 2022 173.69M
December 31, 2021 186.43M
December 31, 2020 174.12M
December 31, 2019 170.02M
Date Value
December 31, 2018 146.63M
December 31, 2017 118.70M
December 31, 2016 153.22M
December 31, 2015 95.70M
December 31, 2014 1.634M
December 31, 2013 7.551M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Innoviva, Inc. 566.67M
Zevra Therapeutics, Inc. 191.01M
Supernus Pharmaceuticals, Inc. 308.67M
Indivior Pharmaceuticals, Inc. 195.00M
Crinetics Pharmaceuticals, Inc. 1.028B